Siga Technologies (SIGA) Cash from Operations Growth (1y) (2011 - 2025)
Siga Technologies (SIGA) Cash from Operations Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.78 Bn | 87.91 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.20 Bn | 1.97 Bn | 61.90% |
| 3 | Zoetis | 32.50 Bn | 30.56 Bn | 1.62 Bn | -22.14% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | 8.20% |
| 5 | United Therapeutics | 23.01 Bn | 20.85 Bn | 648.10 Mn | 0.46% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.41 Bn | 18.61 Bn | 1.16 Bn | -27.49% |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.45 Bn | 800.70 Mn | 125.00% |
| 9 | Elanco Animal Health | 12.66 Bn | 12.23 Bn | 785.00 Mn | 425.00% |
| 10 | Siga Technologies | 224.12 Mn | 69.16 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -32.92% |
| Jun 30, 2025 | 959.64% |
| Mar 31, 2025 | 215.42% |
| Dec 31, 2024 | -28.75% |
| Sep 30, 2024 | -44.79% |
| Jun 30, 2024 | 266.29% |
| Mar 31, 2024 | -125.03% |
| Dec 31, 2023 | 1,074.95% |
| Sep 30, 2023 | -6.65% |
| Jun 30, 2023 | -62.16% |
| Mar 31, 2023 | -56.89% |
| Dec 31, 2022 | -150.34% |
| Sep 30, 2022 | -393.58% |
| Jun 30, 2022 | -54.36% |
| Mar 31, 2022 | 1,279.83% |
| Dec 31, 2021 | -64.95% |
| Sep 30, 2021 | -94.80% |
| Jun 30, 2021 | 84.26% |
| Mar 31, 2021 | -244.66% |
| Dec 31, 2020 | 422.11% |